Exploring treatment alternatives: weekly dosing of fluoxetine for the continuation phase of major depressive disorder
WJ Burke, DA McArthur-Miller - Journal of Clinical Psychiatry, 2001 - psychiatrist.com
Antidepressant medications are typically taken on a daily basis owing to both tradition and
the pharmacokinetics of these agents. Because fluoxetine and its primary metabolite …
the pharmacokinetics of these agents. Because fluoxetine and its primary metabolite …
[HTML][HTML] Selective serotonin reuptake inhibitor drug interactions in patients receiving statins
C Andrade - The Journal of clinical psychiatry, 2014 - psychiatrist.com
Elderly patients commonly receive statin drugs for the primary or secondary prevention of
cardiovascular and cerebrovascular events. Elderly patients also commonly receive …
cardiovascular and cerebrovascular events. Elderly patients also commonly receive …
Long-term treatment outcomes of depression with associated anxiety: efficacy of continuation treatment with fluoxetine
MJ Joliat, ME Schmidt, M Fava, S Zhang… - Journal of Clinical …, 2004 - psychiatrist.com
Background: Severity of anxiety does not appear to influence the antidepressant response to
fluoxetine during acute treatment of major depressive disorder (MDD). We report a …
fluoxetine during acute treatment of major depressive disorder (MDD). We report a …
[引用][C] Cholesterol and lithium levels were correlated but serum HDL and total cholesterol levels were not associated with current mood state in bipolar patients
C Diaz-Sastre, MM Perez-Rodriguez… - The Journal of clinical …, 2005 - psychiatrist.com
Sir: In patients with bipolar I disorder, low total serum cholesterol levels have been reported
during full remission and manic and depressive episodes. 1, 2 Several cohort studies 3-5 …
during full remission and manic and depressive episodes. 1, 2 Several cohort studies 3-5 …
Abnormal CSF monoamine metabolism in serotonin syndrome
K Nisijima, M Nibuya, H Sugiyama - Journal of clinical …, 2003 - journals.lww.com
Downloaded from by BhDMf5ePHKbH4TTImqenVA+
lpWIIBvonhQl60Etgtdnn9T1vLQWJq3kbRMjK/ocE on 11/10/2023 worsening of …
lpWIIBvonhQl60Etgtdnn9T1vLQWJq3kbRMjK/ocE on 11/10/2023 worsening of …
Failure to consider drug-drug interactions as a likely cause of behavioral deterioration in a patient with bipolar disorder
MU Shad, SH Preskorn, Z Izgur - Journal of clinical …, 2000 - journals.lww.com
Discussion The course of this patient's problems could be explained by a series of adverse
drug-drug interactions. The patient's catatonia could be due to an adverse drug-drug …
drug-drug interactions. The patient's catatonia could be due to an adverse drug-drug …
Psychosocial functioning during the treatment of major depressive disorder with fluoxetine
GI Papakostas, T Petersen, JW Denninger… - Journal of clinical …, 2004 - journals.lww.com
Background: Major depressive disorder (MDD) is associated with significant disability,
having a profound impact on psychosocial functioning. Therefore, studying the impact of …
having a profound impact on psychosocial functioning. Therefore, studying the impact of …
Treatment Approaches to Major Depressive Disorder RelapsePart 1: Dose Increase
ME Schmidt, M Fava, S Zhang, J Gonzales… - Psychotherapy and …, 2002 - karger.com
Objective: Although continuing antidepressant treatment after patients have responded to
medication has been shown to greatly reduce the risk of relapse, this risk is not eliminated. A …
medication has been shown to greatly reduce the risk of relapse, this risk is not eliminated. A …
Bromocriptine treatment of relapses seen during selective serotonin re-uptake inhibitor treatment of depression
PJ McGrath, FM Quitkin, DF Klein - Journal of clinical …, 1995 - journals.lww.com
Some patients relapse while taking previously effective doses of selective serotonin
reuptake inhibitor antidepressants (SSRI), as they do with other antidepressants.[1-4] …
reuptake inhibitor antidepressants (SSRI), as they do with other antidepressants.[1-4] …
Factors affecting return of symptoms 1 year after treatment in a 62-week controlled study of fluoxetine in major depression
FW Reimherr, RE Strong, BK Marchant… - Journal of Clinical …, 2001 - psychiatrist.com
Background: In spite of impressive results in acute studies, the long-term treatment of major
depression remains problematic. To explore the return of depressive symptoms and their …
depression remains problematic. To explore the return of depressive symptoms and their …